ATC V03AE02 · All Other Therapeutic Products
Sevelamer shortage
As of 31 Oct 2026, Sevelamer has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 5 products.
Countries3/5
Products5packs or presentations
Short since14 Jul 20264 months ago
Earliest return5 Nov 2026company estimate
No return date3products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | SEVELAMER MYLAN PHARMA | MYLAN S.P.A. | 14 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | SEVELAMER EG STADA | EG S.P.A. | 1 Sep 2026 | not given | Increased demand Elevata richiesta |
| IT | SEVELAMER AUROBINDO announced | AUROBINDO PHARMA (ITALIA) S.R.L. | 8 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | SEVELAMERO VIATRIS 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA,180 comprimidos por envase (con y sin envase de cartón) | Viatris Limited | 3 Sep 2026 | 5 Nov 2026 | Not stated |
| BE | Renvela 0.8 g or. susp. (pwdr.) 90 x 0.8 g | Sanofi Winthrop Industrie | 28 Sep 2026 | 7 Dec 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.